Skip to main content
LGND
NASDAQ Life Sciences

Ligand Invests in Zerion Pharma's Dispersome® Technology, Securing Future Royalties and Equity

Tom Rudovsky · Reported by MFN by Modular Finance
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$308
Mkt Cap
$6.294B
52W Low
$111.715
52W High
$314.8
52W Position info
176% above low
Off High info
2.2% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

LGND has more than doubled off its 52-week low of $111.715.

Summary

Ligand Pharmaceuticals has completed a royalty financing and equity investment with Zerion Pharma, investing an undisclosed amount to advance Zerion's Dispersome® technology. This strategic move grants Ligand a share of future royalty income from the technology and an equity position in Zerion. The Dispersome® technology aims to improve drug solubility and bioavailability, aligning with Ligand's core business as a royalty aggregator. This follows Ligand's recent $739 million acquisition of XOMA Royalty Corporation and a $700 million convertible senior notes offering, further expanding its portfolio of royalty-generating assets.

At the time of this announcement, LGND was trading at $308.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $111.72 to $314.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: MFN by Modular Finance.


Price Chart

Share this article

Copied!

LGND - Latest Insights

LGND
Oct 30, 2026, 4:47 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $324.00
Real-time Price: $296.67 info
Change: -$27.33 (-8%) info
Market Cap: $5.94B info
LGND
Oct 29, 2026, 3:12 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $316.21
Real-time Price: $296.67 info
Change: -$19.54 (-6%) info
Market Cap: $5.94B info
LGND
Oct 29, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $311.87
Real-time Price: $296.67 info
Change: -$15.20 (-5%) info
Market Cap: $5.94B info
LGND
Oct 29, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $311.87
Real-time Price: $296.67 info
Change: -$15.20 (-5%) info
Market Cap: $5.94B info
LGND
Sep 24, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $298.41
Real-time Price: $296.67 info
Change: -$1.74 (-0.58%) info
Market Cap: $5.94B info